These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36931275)

  • 1. Mutations in IFN-γ signaling genes sensitize tumors to immune checkpoint blockade.
    Song E; Chow RD
    Cancer Cell; 2023 Apr; 41(4):651-652. PubMed ID: 36931275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction.
    Qiu J; Xu B; Ye D; Ren D; Wang S; Benci JL; Xu Y; Ishwaran H; Beltra JC; Wherry EJ; Shi J; Minn AJ
    Nat Cancer; 2023 Jan; 4(1):43-61. PubMed ID: 36646856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors.
    Huang T; Li F; Cheng X; Wang J; Zhang W; Zhang B; Tang Y; Li Q; Zhou C; Tu S
    Front Immunol; 2021; 12():619209. PubMed ID: 33790893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interferons in melanoma resistance to immune checkpoint blockade: mechanisms of escape and therapeutic implications.
    Hargadon KM
    Br J Dermatol; 2021 Dec; 185(6):1095-1104. PubMed ID: 34185875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment.
    Ruan R; Li L; Li X; Huang C; Zhang Z; Zhong H; Zeng S; Shi Q; Xia Y; Zeng Q; Wen Q; Chen J; Dai X; Xiong J; Xiang X; Lei W; Deng J
    Mol Cancer; 2023 Mar; 22(1):60. PubMed ID: 36966334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
    Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of
    Chen XJ; Ren AQ; Zheng L; Zheng ED
    Front Immunol; 2021; 12():664847. PubMed ID: 33953726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors.
    Chen Y; Li Y; Guan Y; Huang Y; Lin J; Chen L; Li J; Chen G; Pan LK; Xia X; Xu N; Chang L; Guo Z; Pan J; Yi X; Chen C
    Mol Oncol; 2020 Sep; 14(9):2096-2110. PubMed ID: 32502294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics modulates the complexity of the response to Immune Checkpoint Blockade.
    Barragan I
    EBioMedicine; 2020 Oct; 60():103005. PubMed ID: 32987318
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance.
    Li Y; Liu J; Gao L; Liu Y; Meng F; Li X; Qin FX
    Immunol Lett; 2020 Apr; 220():88-96. PubMed ID: 30885690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment.
    Aoyama S; Nakagawa R; Nemoto S; Perez-Villarroel P; Mulé JJ; Mailloux AW
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34135102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors.
    Li Y; Zhang Y; Cao G; Zheng X; Sun C; Wei H; Tian Z; Xiao W; Sun R; Sun H
    J Hematol Oncol; 2021 Jun; 14(1):100. PubMed ID: 34174928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment.
    Song Y; Fu Y; Xie Q; Zhu B; Wang J; Zhang B
    Front Immunol; 2020; 11():1956. PubMed ID: 32983126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy.
    Zappasodi R; Cook GP; Taylor A
    Front Immunol; 2022; 13():1120207. PubMed ID: 36618416
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors.
    Ahn R; Ursini-Siegel J
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers.
    Cheng L; Wang Y; Qiu L; Chang Y; Lu H; Liu C; Zhang B; Zhou Y; Bai H; Xiong L; Zhong H; Nie W; Han B
    J Transl Med; 2022 May; 20(1):247. PubMed ID: 35642038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.
    Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.
    Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromothripsis is correlated with reduced cytotoxic immune infiltration and diminished responsiveness to checkpoint blockade immunotherapy.
    Chu H; Jin Z; Cheng JN; Jia Q; Zhu B; Cai H
    Theranostics; 2023; 13(4):1443-1453. PubMed ID: 36923532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.